A new market
report published by Transparency Market Research entitled: "Assisted
Reproductive Technology Market: (Global Industry Analysis, Size, Share, Growth
Trends and Forecast, 2017 - 2025" shows that the global
market for Assisted reproductive Technology (ART) was valued at $2,210.0
million in 2016 and is estimated
to reach $3,779.0 million by
2024 at a CAGR of 6.3 per cent from 2017 to 2025.
Assisted Reproductive
Technology (ART) are treatments for
infertility, performed to achieve a child birth. The ART procedures includes
artificial insemination or stimulation of ovaries to increase egg production,
or procedures where the eggs and sperm are combined in a laboratory (in vitro)
and the resulting embryo is transferred to a woman to attain pregnancy.
Delay in
childbearing age to pursue higher education and career growth which has
increase the demand for ART treatment.
Increasing
population of women of advanced reproductive age is seeking for assisted
reproductive technology (ART) treatment due to age-related infertility.
Adoption of ART has increased worldwide but rise have been most boosted in
jurisdictions that provide public funding for ART treatment.
The rising
incidence of infertility, high success rate of ART treatment and increase in
number of fertility clinics worldwide has gain popularity among the patients
for adoption of ART treatment which has augmented the growth of assisted
reproductive technology market.
The global ART
market is segmented into technology, procedure, end users and regions. Based on
technology, the assisted reproductive technology market is segmented as in IVF,
artificial insemination, surrogacy and others. The IVF market is segmented into
intra cytoplasmic sperm injection (ICSI) and pre-implantation genetic
diagnostic (PGD).
Artificial
insemination is segmented into intrauterine insemination and intracervical
insemination and others. In vitro fertilization is the major segment of
technology in the assisted reproductive technology market.
High success rate
and technological advancement in development of new devices for IVF treatment
are likely to propel the expansion of the segment during the forecast
period.
Rise in rate of
male infertility, low cost of artificial insemination technology and surrogacy
in developing nations, rising incidence of reproductive tourism & cross
border reproductive care are estimated to drive the market of artificial
insemination and surrogacy segment during forecast period. The others segment
is anticipated to remain steady during the forecast period due to the high cost
and less awareness of GIFT and ZIFT technologies and dominance of IVF and
surrogacy in the global market.
Based on
procedure, the market is segmented into frozen donor, frozen non donor, fresh
donor, fresh non donor, and embryo banking. Fresh non donor segment accounted
to hold the largest market share in 2016, due to low cost of overall treatment
with usage of own egg, and high rate of success of ART cycle with usage of
fresh non donor procedure.
Frozen non donor
is the second largest segment and is likely to be driven by development of new
technology for freezing, rise in awareness about medical fertility
preservation, and initiatives by governments in opening and expansion of
fertility preservation centres.
Based on end
user, the assisted reproductive technology market is segmented into fertility
clinics, hospitals and others. Fertility clinics accounted to hold the largest
market share in 2016, due to constant rise in fertility clinics, high success
rate of fertility treatment in clinics due to adoption of advance technology,
tie up of clinics with consultant, and rising fertility tourism.
The hospitals
segment is expected to grow by 2024 due to advanced procedures and equipment,
availability of expert doctors, and ongoing research in hospitals for improving
the success rate and technology in ART treatment.
The Global
Assisted Reproductive Technology Market is segmented by Technology as
follows:
In Vitro
Fertilization, Intra-cytoplasmic Sperm Injection (ICSI), Preimplantation
Genetic Diagnosis (PGD), Artificial Insemination, Intrauterine Insemination
(IUI), Intracervical Insemination (ICI) and
Surrogacy among others.
